Sinopharm: revenue by category 2024| ��ƽ��

Revenue of Sinopharm Group Co., Ltd. from 2014 to 2024, by category (in million yuan)

Characteristic	Sales of goods	Financial lease interest income	Consulting income	Logistics services income	Operating lease income	Franchise fees and other service fees from medicine chain stores	Import agency income	Other	Marketing service income
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Source

Release date

April 2025

More information

Region

China

Survey time period

2014 to 2024

Supplementary notes

One yuan equals approximately 0.14 U.S. dollars and 0.12 euros (as of September 2025).

Figures have been rounded.

Citation formats

In 2024, the Chinese pharmaceutical giant Sinopharm group reported annual revenue of over *** billion yuan. The vast majority of the company's revenue was generated by the sale of products, including medicine and medical equipment.

Other statistics on the topic
Chinese COVID-19 vaccines

Top 10 global pharmaceutical companies by revenue 2025

Leading biotech and pharmaceutical companies 2026, by revenue

Top pharmaceutical companies located in Canada 2023, by revenue

Major biotech and pharmaceutical companies global 2026 by employees

Access all statistics starting from $2,388 USD yearly ^*

* For commercial use only

For single users

$0 USD

Always free

Access limited to Free Statistics. Premium Statistics are not included.

Free Statistics

Based on your interests

For single users

$199 USD

per month, billed annually ¹

Buy now

Free Statistics
Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.

For teams of up to 99 users

Talk to sales for pricing

Free + Premium Statistics
Reports
Market ��ƽ��

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Chinese COVID-19 vaccines "

The most important statistics

Other statistics that may interest you Chinese COVID-19 vaccines

Overview

Sinovac

Sinopharm and CanSino

Domestic adoption

Exports

Further Content: You might find this interesting as well

Topics

Chinese COVID-19 vaccines

Coronavirus COVID-19 in China

Pharmaceutical industry in China

Vaccine industry in China

Coronavirus disease (COVID-19) pandemic

Access all statistics starting from $2,388 USD yearly ^*

* For commercial use only

For single users

$0 USD

Always free

Access limited to Free Statistics. Premium Statistics are not included.

Free Statistics

Based on your interests

For single users

$199 USD

per month, billed annually ¹

Buy now

Free Statistics
Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.

For teams of up to 99 users

Talk to sales for pricing

Free + Premium Statistics
Reports
Market ��ƽ��

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Learn more about how ��ƽ�� can support your business.

Characteristic	Sales of goods	Financial lease interest income	Consulting income	Logistics services income	Operating lease income	Franchise fees and other service fees from medicine chain stores	Import agency income	Other	Marketing service income
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-

Characteristic	Sales of goods	Financial lease interest income	Consulting income	Logistics services income	Operating lease income	Franchise fees and other service fees from medicine chain stores	Import agency income	Other	Marketing service income
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-

�����ƽ��

Revenue of Sinopharm Group Co., Ltd. from 2014 to 2024, by category (in million yuan)

Other statistics on the topicChinese COVID-19 vaccines

Statistics on " Chinese COVID-19 vaccines "

Other statistics that may interest you Chinese COVID-19 vaccines

Further Content: You might find this interesting as well

Topics

��ƽ��

Other statistics on the topic
Chinese COVID-19 vaccines

Characteristic	Sales of goods	Financial lease interest income	Consulting income	Logistics services income	Operating lease income	Franchise fees and other service fees from medicine chain stores	Import agency income	Other	Marketing service income
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-